Vania Baldan

785 total citations
9 papers, 360 citations indexed

About

Vania Baldan is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Vania Baldan has authored 9 papers receiving a total of 360 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 4 papers in Molecular Biology and 2 papers in Immunology. Recurrent topics in Vania Baldan's work include CAR-T cell therapy research (7 papers), Viral Infectious Diseases and Gene Expression in Insects (2 papers) and Advancements in Semiconductor Devices and Circuit Design (2 papers). Vania Baldan is often cited by papers focused on CAR-T cell therapy research (7 papers), Viral Infectious Diseases and Gene Expression in Insects (2 papers) and Advancements in Semiconductor Devices and Circuit Design (2 papers). Vania Baldan collaborates with scholars based in United Kingdom. Vania Baldan's co-authors include Robert E. Hawkins, David E. Gilham, Hannah Gornall, Richard W. Griffiths, Eleanor J. Cheadle, Vivien Hanson, Shimobi Onuoha, Martin Pulé, Simon Thomas and Reyisa Bughda and has published in prestigious journals such as Blood, Cancer Research and Journal of Virology.

In The Last Decade

Vania Baldan

9 papers receiving 356 citations

Peers

Vania Baldan

ONCOL

IMMUN

MB

BE

GENET

Paul Castillo United States

Jiazhen Cui China

Reyisa Bughda United Kingdom

Ruimin Hong China

Justin C. Boucher United States

Brynn B. Duncan United States

Ryo Hanajiri Japan

Mark Enstrom United States

Thomas Shum United States

Mingzhi Zhang China

Paul Castillo United States

Vania Baldan

331 ×1.1

ONCOL

154 ×1.1

IMMUN

130 ×1.2

MB

130 ×1.6

BE

100 ×1.4

GENET

Citations per year, relative to Vania Baldan Vania Baldan (= 1×) peers Paul Castillo

Countries citing papers authored by Vania Baldan

Since Specialization

Citations

This map shows the geographic impact of Vania Baldan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vania Baldan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vania Baldan more than expected).

Fields of papers citing papers by Vania Baldan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vania Baldan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vania Baldan. The network helps show where Vania Baldan may publish in the future.

Co-authorship network of co-authors of Vania Baldan

This figure shows the co-authorship network connecting the top 25 collaborators of Vania Baldan. A scholar is included among the top collaborators of Vania Baldan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vania Baldan. Vania Baldan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

1.

Bulek, Anna, Mathew Robson, Evangelia Kokalaki, et al.. (2023). Exploration of T cell immune responses by expression of a dominant-negative SHP1 and SHP2. Frontiers in Immunology. 14. 1119350–1119350. 3 indexed citations

2.

Ferrari, Mathieu, Leila Mekkaoui, Reyisa Bughda, et al.. (2021). Characterization of a Novel ACE2-Based Therapeutic with Enhanced Rather than Reduced Activity against SARS-CoV-2 Variants. Journal of Virology. 95(19). e0068521–e0068521. 25 indexed citations

3.

Ferrari, Mathieu, Vania Baldan, Reyisa Bughda, et al.. (2020). Abstract 2183: Targeting TRBC1 and 2 for the treatment of T cell lymphomas. Cancer Research. 80(16_Supplement). 2183–2183. 5 indexed citations

4.

Baldan, Vania, Evangelia Kokalaki, Shimobi Onuoha, et al.. (2017). A Dominant Negative SHP-2 Which Abrogates PD-1 Signalling Pathways and Restores Function of Cytotoxic CAR T Cells. Blood. 130. 3190–3190. 5 indexed citations

5.

Thomas, Simon, Vania Baldan, Evangelia Kokalaki, et al.. (2017). A DUAL TARGETING CAR‐T CELL APPROACH FOR THE TREATMENT OF B CELL MALIGNANCIES. Hematological Oncology. 35(S2). 261–261. 1 indexed citations

6.

Lee, Lydia, Benjamin Draper, Brian Philip, et al.. (2017). An APRIL-based chimeric antigen receptor for dual targeting of BCMA and TACI in multiple myeloma. Blood. 131(7). 746–758. 134 indexed citations

7.

Baldan, Vania, Richard W. Griffiths, Robert E. Hawkins, & David E. Gilham. (2015). Efficient and reproducible generation of tumour-infiltrating lymphocytes for renal cell carcinoma. British Journal of Cancer. 112(9). 1510–1518. 63 indexed citations

8.

Alcantar-Orozco, Erik, Hannah Gornall, Vania Baldan, Robert E. Hawkins, & David E. Gilham. (2013). Potential Limitations of the NSG Humanized Mouse as a Model System to Optimize Engineered Human T cell Therapy for Cancer. Human Gene Therapy Methods. 24(5). 310–320. 34 indexed citations

9.

Cheadle, Eleanor J., Hannah Gornall, Vania Baldan, et al.. (2013). CAR T cells: driving the road from the laboratory to the clinic. Immunological Reviews. 257(1). 91–106. 90 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact